Innovative Clinical Research Institute (ICRI)

Whittier, California 90603

We've found

5 trials

at this facility

A Study of Melflufen in Combination With Dexamethasone in Relapsed Refractory Multiple Myeloma Patients

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Whittier, CA

Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers

Status: Enrolling, Phase I, II
Updated: 12/31/1969

from

Whittier, CA

Study of AM0010 With Nivolumab Compared to Nivolumab Alone Second-line Tx in Patients With Metastatic Non-Small Cell Lung Cancer

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Whittier, CA

Study of AM0010 With Pembrolizumab Compared to Pembrolizumab Alone First-line Tx in Patients With Metastatic Non-Small Cell Lung Cancer

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Whittier, CA

A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer (FIGHT)

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Whittier, CA

Use our guide to learn which trials are right for you!